A structured multidomain lifestyle intervention may help slow the progression of brain white matter changes in adults under age 70, according to findings from the POINTER Imaging study presented at the Alzheimer’s Association International Conference. Researchers found that compared to a self-guided approach, a structured program—incorporating physical activity, diet, social engagement, and cardiovascular monitoring—attenuated increases in white matter free water (β = -0.031, SE=0.012, P=0.009), a key marker of brain aging.
The Window of Opportunity for Brain Health
The study, published in JAMA Network Open, suggests a critical age-related threshold for intervention. While participants under 70 showed measurable biological benefits in their white matter, these effects were not observed in those 70 and older. Pauline Maillard, PhD, of the University of California Davis, noted that these findings indicate that intervening before age 70 may be especially beneficial for preserving brain health.
White matter changes are often overlooked in favor of memory-related markers, but they are vital indicators of vascular health and connectivity. “Our findings support the idea that addressing several modifiable risk factors together… may have measurable effects on the brain,” Maillard told MedPage Today. She emphasized that while these results don’t prove lifestyle changes alone can prevent dementia, they provide biological evidence that lifestyle interventions influence the trajectory of brain aging.
Did you know?
White matter free water is a sensitive marker for small-vessel disease. According to the POINTER Imaging analysis, baseline levels of free water can help identify individuals at higher risk for future white matter hyperintensity progression and cerebral microbleeds.
Comparing Structured vs. Self-Guided Interventions
The POINTER trial followed over 2,000 older adults to compare two distinct approaches to lifestyle management. Both groups were encouraged to improve their diet, exercise, and social habits, but the structured arm differed in structure, intensity, and accountability.
The primary trial results, released in 2025, showed that the structured group experienced greater cognitive benefits, with researchers estimating the intervention slowed the “cognitive aging clock” by approximately 1 to 2 years. Ancillary studies, including POINTER-NV (neurovascular) and POINTER-Neuroimaging, further confirmed that this structured approach led to superior outcomes in blood pressure regulation, sleep apnea management, and cognitive resilience.
Future Directions in Prevention Science
Following the success of the POINTER trial and the LatAm-FINGERS study—which demonstrated cognitive improvements via lifestyle intervention in Latin American populations—the organization has launched the global PROTECT-Cog trial.
PROTECT-Cog will investigate whether combining lifestyle modifications with metabolism-targeting drugs, such as GLP-1 receptor agonists, can further delay cognitive decline. “By testing a combined approach that targets both lifestyle and biology, we have the opportunity to better understand how to meaningfully reduce the risk of cognitive decline before symptoms begin,” said Maria Carrillo, PhD, chief science officer and medical affairs lead at the Alzheimer’s Association.
Pro Tip: Focus on the “Multidomain” Approach
Current research emphasizes that single-factor interventions are rarely enough. Experts suggest that the most effective way to support brain health is to simultaneously address physical activity, healthy diet, cognitive stimulation, and cardiovascular risk factors like blood pressure.
Frequently Asked Questions
Can lifestyle changes prevent dementia?
According to Dr. Maillard, current results should not be interpreted as showing that lifestyle interventions alone can prevent dementia. However, they provide evidence that these changes can influence brain aging and potentially slow cognitive decline.
Why does age 70 seem to be a cutoff for these benefits?
The POINTER Imaging analysis found that while adults aged 60 to 70 showed attenuated white matter injury through structured intervention, this effect was not seen in participants 70 and older. This suggests that earlier intervention is more effective for preserving white matter health.
What is the role of the PROTECT-Cog trial?
PROTECT-Cog is designed to test if adding metabolism-targeting drugs (like GLP-1 agonists) to lifestyle interventions is more effective at preventing cognitive decline than lifestyle changes alone.
Are you interested in how lifestyle changes affect long-term health? Subscribe to our newsletter for the latest updates on brain health research and clinical trial outcomes.
Related reading
